124 related articles for article (PubMed ID: 38324380)
21. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
[TBL] [Abstract][Full Text] [Related]
22. Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA.
Xiao G; Wesolowski D; Izadjoo M; Altman S
RNA; 2010 Nov; 16(11):2218-25. PubMed ID: 20817753
[TBL] [Abstract][Full Text] [Related]
23. Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice switching morpholino oligonucleotide in spinal muscular atrophy patient-derived fibroblasts.
Tajik-Ahmadabad B; Polyzos A; Separovic F; Shabanpoor F
Int J Pharm; 2017 Oct; 532(1):21-28. PubMed ID: 28864392
[TBL] [Abstract][Full Text] [Related]
24. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy.
Shabanpoor F; Hammond SM; Abendroth F; Hazell G; Wood MJA; Gait MJ
Nucleic Acid Ther; 2017 Jun; 27(3):130-143. PubMed ID: 28118087
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.
Alonso M; Stein DA; Thomann E; Moulton HM; Leong JC; Iversen P; Mourich DV
J Fish Dis; 2005 Jul; 28(7):399-410. PubMed ID: 16083445
[TBL] [Abstract][Full Text] [Related]
27. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
28. MOTS-c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice.
Ran N; Lin C; Leng L; Han G; Geng M; Wu Y; Bittner S; Moulton HM; Yin H
EMBO Mol Med; 2021 Feb; 13(2):e12993. PubMed ID: 33337582
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of Phosphorodiamidate Morpholino Oligonucleotides and Their Chimeras Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
J Am Chem Soc; 2016 Dec; 138(48):15663-15672. PubMed ID: 27934012
[TBL] [Abstract][Full Text] [Related]
30. Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.
Betts C; Saleh AF; Arzumanov AA; Hammond SM; Godfrey C; Coursindel T; Gait MJ; Wood MJ
Mol Ther Nucleic Acids; 2012 Aug; 1(8):e38. PubMed ID: 23344180
[TBL] [Abstract][Full Text] [Related]
31. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
Deere J; Iversen P; Geller BL
Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
[TBL] [Abstract][Full Text] [Related]
32. Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides.
Wolfe JM; Fadzen CM; Holden RL; Yao M; Hanson GJ; Pentelute BL
Angew Chem Int Ed Engl; 2018 Apr; 57(17):4756-4759. PubMed ID: 29479836
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
[TBL] [Abstract][Full Text] [Related]
34. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Moulton HM; Fletcher S; Neuman BW; McClorey G; Stein DA; Abes S; Wilton SD; Buchmeier MJ; Lebleu B; Iversen PL
Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
[TBL] [Abstract][Full Text] [Related]
35. Cell-Penetrating d-Peptides Retain Antisense Morpholino Oligomer Delivery Activity.
Schissel CK; Farquhar CE; Malmberg AB; Loas A; Pentelute BL
ACS Bio Med Chem Au; 2022 Apr; 2(2):150-160. PubMed ID: 37101743
[TBL] [Abstract][Full Text] [Related]
36. Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide.
Haque US; Yokota T
Cells; 2023 Oct; 12(19):. PubMed ID: 37830609
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Biophysical Properties of Phosphorodiamidate Piperidino Oligomers.
Ghosh A; Akabane-Nakata M; Kundu J; Harp JM; Madaoui M; Egli M; Manoharan M; Sinha S
Org Lett; 2023 Feb; 25(6):901-906. PubMed ID: 36734846
[TBL] [Abstract][Full Text] [Related]
38. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
[TBL] [Abstract][Full Text] [Related]
39. Development of novel bioanalytical methods to determine the effective concentrations of phosphorodiamidate morpholino oligomers in tissues and cells.
Schnell FJ; Crumley SL; Mourich DV; Iversen PL
Biores Open Access; 2013 Feb; 2(1):61-6. PubMed ID: 23515175
[TBL] [Abstract][Full Text] [Related]
40. Internal Oligoguanidinium-Based Cellular Transporter Enhances Antisense Efficacy of Morpholinos in In Vitro and Zebrafish Model.
Bhadra J; Pattanayak S; Khan PP; Kundu J; Sinha S
Bioconjug Chem; 2016 Oct; 27(10):2254-2259. PubMed ID: 27625020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
